Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained Treatment Success With Ustekinumab in Symptomatic Stricturing Crohn's Disease: A Retrospective Single-Arm Observational Cohort Study.

MedComm·2026
Same author

Decoding the microbiome: artificial intelligence-targeted gut microenvironment breakthroughs in personalized cancer therapy.

Gut microbes·2026
Same author

Deciphering Angiogenic Drivers in Hepatocellular Carcinoma: From Prognostic Signature Construction to Genistein-Mediated Inhibition.

Journal of cellular and molecular medicine·2026
Same author

Prebiotic-Empowered Probiotics with Gastrointestinal Stress Resistance for Enhanced Oral Therapy of Immunosuppression.

Foods (Basel, Switzerland)·2026
Same author

Protein-Glutaminase-Mediated Deamidation Enhances the Functional Properties of Walnut Protein Concentrate for Food Applications.

Journal of food science·2026
Same author

Olfactory epithelium organoid models identify Ddit3 as a potential therapeutic target against inflammation-related olfactory sensory neuronal loss and functional deficit.

International journal of biological sciences·2026
Same journal

A senescent metabolism-modulating hierarchical scaffold restores NAD<sup>+</sup> homeostasis and redox balance for aged bone repair.

Bioactive materials·2026
Same journal

Intelligent responsive alloy scaffold temporally regulates the immune-osteogenic axis for the treatment of infectious bone defects.

Bioactive materials·2026
Same journal

Polymer-Zn(II) sunscreens for protection against harmful blue ray.

Bioactive materials·2026
Same journal

M1 macrophage-derived exosomal miR-155-5p exacerbates aortic dissection via SMAD5-Mediated regulation of vascular smooth muscle cell phenotype.

Bioactive materials·2026
Same journal

Immunity-and-matrix-regulatory cells promote hyaline-like cartilage repair in osteoarthritis.

Bioactive materials·2026
Same journal

Injectable chondroitin sulfate-glycosylated decellularized extracellular matrix microgels activate Wnt/β-Catenin signaling to promote functional muscle regeneration in VML.

Bioactive materials·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2025

Generation of Dynamical Environmental Conditions using a High-Throughput Microfluidic Device
14:48

Generation of Dynamical Environmental Conditions using a High-Throughput Microfluidic Device

Published on: April 17, 2021

4.0K

Dynamic microphysiological system chip platform for high-throughput, customizable, and multi-dimensional drug

Yuxuan Zhu1,2, Deming Jiang1,3, Yong Qiu1

  • 1Biosensor National Special Laboratory, Key Laboratory of Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China.

Bioactive Materials
|May 27, 2024
PubMed
Summary
This summary is machine-generated.

A novel Microphysiological System Chip Platform (MSCP) enables high-throughput drug screening using lung cancer spheroids. This dynamic system accurately models disease and assesses drug efficacy for personalized medicine.

Keywords:
BiomimeticsHigh throughputMicrophysiological systemMultidimensional drug screeningOrgan-on-a-chip

More Related Videos

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
15:41

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells

Published on: October 15, 2013

14.9K
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
13:42

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

11.8K

Related Experiment Videos

Last Updated: Jun 25, 2025

Generation of Dynamical Environmental Conditions using a High-Throughput Microfluidic Device
14:48

Generation of Dynamical Environmental Conditions using a High-Throughput Microfluidic Device

Published on: April 17, 2021

4.0K
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
15:41

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells

Published on: October 15, 2013

14.9K
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
13:42

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

11.8K

Area of Science:

  • Biomedical Engineering
  • Drug Discovery
  • Oncology

Background:

  • Spheroids and organoids are advanced models for disease simulation and drug testing.
  • Microphysiological systems (MPS) offer enhanced precision in disease modeling and drug screening.
  • High-throughput MPS are crucial for personalized medicine and pharmaceutical research but are complex to develop.

Purpose of the Study:

  • To introduce a dynamic Microphysiological System Chip Platform (MSCP) with advanced microstructures.
  • To establish a high-throughput lung cancer spheroids model and a multi-organ MPS for drug testing.
  • To demonstrate the MSCP's capability for parallel drug evaluation and assessment of systemic drug effects.

Main Methods:

  • Development of a Microphysiological System Chip Platform (MSCP) with multiple functional microstructures.
  • Creation of a high-throughput lung cancer spheroids model.
  • Construction of a multi-organ (intestine-liver-heart-lung cancer) MPS for parallel drug testing.

Main Results:

  • Successful development and demonstration of the Microphysiological System Chip Platform (MSCP).
  • Establishment of a high-throughput lung cancer spheroids model and a multi-organ MPS.
  • Feasibility shown for parallel testing of four anti-lung cancer drugs, assessing efficacy and systemic effects.

Conclusions:

  • The Microphysiological System Chip Platform (MSCP) is a versatile tool for advanced disease modeling and drug screening.
  • The MSCP enables comprehensive assessment of drug efficacy and side effects by simulating physiological communication.
  • This platform significantly contributes to microphysiological system research, drug development, and personalized medical treatments.